Julian Adams - Xconomy

by in

Entry	Author	Date	Location
Infinity Pharmaceuticals Bounces Back To Compete in Crowded Field	Luke Timmerman	02/08/13	Boston
Fearless Football and Biotech Picks For Fall 2012	Luke Timmerman	09/04/12	National
Infinity Offers Hint Of Effect With Pancreatic Cancer Drug	Luke Timmerman	01/20/12	Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO	Luke Timmerman	11/03/11	Boston
Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend	Luke Timmerman	06/02/11	Boston
Infinity Pharma, Intellikine Strike Deal to Make Cancer Drugs Against Hot Target	Luke Timmerman	07/08/10	Boston
Infinity’s New CEO, Veteran Dealmaker, Seeks to Deliver on Company’s Early Promise	Luke Timmerman	02/09/10	Boston
Infinity Sees Comeback Potential for Cancer Drug that Failed	Luke Timmerman	06/01/09	Boston
Infinity Pharmaceuticals Gets Back Full Rights to Cancer Drugs From AstraZeneca	Luke Timmerman	12/11/08	Boston
Page 1 of 1

Xconomy National